{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:31:16Z","timestamp":1790353876289,"version":"4.1.0"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T00:00:00Z","timestamp":1711411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T00:00:00Z","timestamp":1711411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002947","name":"Anhui Medical University","doi-asserted-by":"publisher","award":["2023xkj066"],"award-info":[{"award-number":["2023xkj066"]}],"id":[{"id":"10.13039\/501100002947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002947","name":"Anhui Medical University","doi-asserted-by":"publisher","award":["2020xkj050"],"award-info":[{"award-number":["2020xkj050"]}],"id":[{"id":"10.13039\/501100002947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002947","name":"Anhui Medical University","doi-asserted-by":"publisher","award":["2019xkj162"],"award-info":[{"award-number":["2019xkj162"]}],"id":[{"id":"10.13039\/501100002947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Disulfidptosis, a newly discovered type of programmed cell death, could be a mechanism of cell death controlled by SLC7A11. This could be closely associated with tumor development and advancement. Nevertheless, the biological mechanism behind disulfidptosis-related genes (DRGs) in sarcoma (SARC) is uncertain. This study identified three valuable genes (\n                    <jats:italic>SLC7A11, RPN1, GYS1<\/jats:italic>\n                    ) associated with disulfidptosis in sarcoma (SARC) and developed a prognostic model. The multiple databases and RT-qPCR data confirmed the upregulated expression of prognostic DRGs in SARC. The TCGA internal and ICGC external validation cohorts were utilized to validate the predictive model capacity. Our analysis of DRG riskscores revealed that the low-risk group exhibited a more favorable prognosis than the high-risk group. Furthermore, we observed a significant association between DRG riskscores and different clinical features, immune cell infiltration, immune therapeutic sensitivity, drug sensitivity, and RNA modification regulators. In addition, two external independent immunetherapy datasets and clinical tissue samples were collected, validating the value of the DRGs risk model in predicting immunotherapy response. Finally, the SLC7A11\/hsa-miR-29c-3p\/LINC00511, and RPN1\/hsa-miR-143-3p\/LINC00511 regulatory axes were constructed. This study provided DRG riskscore signatures to predict prognosis and response to immunotherapy in SARC, guiding personalized treatment decisions.\n                  <\/jats:p>","DOI":"10.1038\/s41598-024-57594-x","type":"journal-article","created":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T09:04:28Z","timestamp":1711443868000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Correlation analysis of disulfidptosis-related gene signatures with clinical prognosis and immunotherapy response in sarcoma"],"prefix":"10.1038","volume":"14","author":[{"given":"Juan","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangwen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoan","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuewei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanjuan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haotian","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,26]]},"reference":[{"key":"57594_CR1","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1093\/qjmed\/hcab014","volume":"115","author":"M Vasella","year":"2022","unstructured":"Vasella, M. et al. Targeted therapies and checkpoint inhibitors in sarcoma. QJM 115, 793\u2013805 (2022).","journal-title":"QJM"},{"key":"57594_CR2","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.pcl.2014.09.012","volume":"62","author":"JH HaDuong","year":"2015","unstructured":"HaDuong, J. H., Martin, A. A., Skapek, S. X. & Mascarenhas, L. Sarcomas. Pediatr Clin North Am. 62, 179\u2013200 (2015).","journal-title":"Pediatr Clin North Am."},{"key":"57594_CR3","doi-asserted-by":"publisher","first-page":"188606","DOI":"10.1016\/j.bbcan.2021.188606","volume":"1876","author":"F Tang","year":"2021","unstructured":"Tang, F., Tie, Y., Wei, Y. Q., Tu, C. Q. & Wei, X. W. Targeted and immuno-based therapies in sarcoma: mechanisms and advances in clinical trials. Biochim Biophys Acta Rev Cancer. 1876, 188606 (2021).","journal-title":"Biochim Biophys Acta Rev Cancer."},{"key":"57594_CR4","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","volume":"185","author":"BR Stockwell","year":"2022","unstructured":"Stockwell, B. R. Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications. Cell. 185, 2401\u20132421 (2022).","journal-title":"Cell."},{"key":"57594_CR5","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41556-023-01091-2","volume":"25","author":"X Liu","year":"2023","unstructured":"Liu, X. et al. Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis. Nat. Cell Biol. 25, 404\u2013414 (2023).","journal-title":"Nat. Cell Biol."},{"key":"57594_CR6","doi-asserted-by":"publisher","first-page":"19721","DOI":"10.1074\/jbc.M117.814392","volume":"292","author":"T Goji","year":"2017","unstructured":"Goji, T., Takahara, K., Negishi, M. & Katoh, H. Cystine uptake through the cystine\/glutamate antiporter xCT triggers glioblastoma cell death under glucose deprivation. J. Biol. Chem. 292, 19721\u201319732 (2017).","journal-title":"J. Biol. Chem."},{"key":"57594_CR7","doi-asserted-by":"publisher","first-page":"14240","DOI":"10.1074\/jbc.M117.798405","volume":"292","author":"P Koppula","year":"2017","unstructured":"Koppula, P., Zhang, Y., Shi, J., Li, W. & Gan, B. The glutamate\/cystine antiporter SLC7A11\/xCT enhances cancer cell dependency on glucose by exporting glutamate. J. Biol. Chem. 292, 14240\u201314249 (2017).","journal-title":"J. Biol. Chem."},{"key":"57594_CR8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00726-011-0862-x","volume":"42","author":"J Lewerenz","year":"2012","unstructured":"Lewerenz, J., Maher, P. & Methner, A. Regulation of xCT expression and system X (C) (\u2212) function in neuronal cells. Amino Acids. 42, 171\u2013179 (2012).","journal-title":"Amino Acids."},{"key":"57594_CR9","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/s41419-023-05966-y","volume":"14","author":"W Guo","year":"2023","unstructured":"Guo, W. et al. Super-enhancer-driven MLX mediates redox balance maintenance via SLC7A11 in osteosarcoma. Cell Death Dis. 14, 439 (2023).","journal-title":"Cell Death Dis."},{"key":"57594_CR10","doi-asserted-by":"publisher","first-page":"4525","DOI":"10.1007\/s11033-022-07296-2","volume":"49","author":"P He","year":"2022","unstructured":"He, P. et al. CircKIF4A enhances osteosarcoma proliferation and metastasis by sponging MiR-515-5p and upregulating SLC7A11. Mol. Biol. Rep. 49, 4525\u20134535 (2022).","journal-title":"Mol. Biol. Rep."},{"key":"57594_CR11","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.3390\/molecules24142665","volume":"24","author":"Z Yue","year":"2019","unstructured":"Yue, Z. et al. Diallyl disulfide induces apoptosis and autophagy in human osteosarcoma MG-63 cells through the PI3K\/Akt\/mTOR pathway. Molecules. 24, 2665 (2019).","journal-title":"Molecules."},{"key":"57594_CR12","doi-asserted-by":"publisher","first-page":"7286","DOI":"10.1002\/jcb.28003","volume":"120","author":"Y Li","year":"2019","unstructured":"Li, Y., Wang, Z., Li, J. & Sang, X. Diallyl disulfide suppresses FOXM1-mediated proliferation and invasion in osteosarcoma by upregulating miR-134. J. Cell Biochem. 120, 7286\u20137296 (2019).","journal-title":"J. Cell Biochem."},{"key":"57594_CR13","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/jjco\/hyab005","volume":"51","author":"E Nakata","year":"2021","unstructured":"Nakata, E. et al. Immunotherapy for sarcomas. Jpn. J. Clin. Oncol. 51, 523\u2013537 (2021).","journal-title":"Jpn. J. Clin. Oncol."},{"key":"57594_CR14","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s11864-022-00944-6","volume":"23","author":"T Dajsakdipon","year":"2022","unstructured":"Dajsakdipon, T., Siripoon, T., Ngamphaiboon, N., Ativitavas, T. & Dejthevaporn, T. Immunotherapy and biomarkers in sarcoma. Curr. Treat. Options Oncol. 23, 415\u2013438 (2022).","journal-title":"Curr. Treat. Options Oncol."},{"key":"57594_CR15","doi-asserted-by":"publisher","first-page":"6106","DOI":"10.7150\/thno.72800","volume":"12","author":"M Panagi","year":"2022","unstructured":"Panagi, M., Pilavaki, P., Constantinidou, A. & Stylianopoulos, T. Immunotherapy in soft tissue and bone sarcoma: Unraveling the barriers to effectiveness. Theranostics 12, 6106\u20136129 (2022).","journal-title":"Theranostics"},{"key":"57594_CR16","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13046-023-02675-4","volume":"42","author":"P Zheng","year":"2023","unstructured":"Zheng, P., Zhou, C., Ding, Y. & Duan, S. Disulfidptosis: A new target for metabolic cancer therapy. J. Exp. Clin. Cancer Res. 42, 103 (2023).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"57594_CR17","doi-asserted-by":"publisher","first-page":"6001","DOI":"10.2147\/OTT.S171791","volume":"11","author":"X Zhang","year":"2018","unstructured":"Zhang, X. et al. Application of weighted gene co-expression network analysis to identify key modules and hub genes in oral squamous cell carcinoma tumorigenesis. Onco Targets Ther. 11, 6001\u20136021 (2018).","journal-title":"Onco Targets Ther."},{"key":"57594_CR18","first-page":"1824","volume":"12","author":"Y Guo","year":"2022","unstructured":"Guo, Y., Ren, C., Huang, W., Yang, W. & Bao, Y. Oncogenic ACSM1 in prostate cancer is through metabolic and extracellular matrix-receptor interaction signaling pathways. Am. J. Cancer Res. 12, 1824\u20131842 (2022).","journal-title":"Am. J. Cancer Res."},{"key":"57594_CR19","doi-asserted-by":"publisher","first-page":"4932","DOI":"10.7150\/ijbs.76425","volume":"18","author":"P Zhang","year":"2022","unstructured":"Zhang, P. et al. CPNE8 promotes gastric cancer metastasis by modulating focal adhesion pathway and tumor microenvironment. Int. J. Biol. Sci. 18, 4932\u20134949 (2022).","journal-title":"Int. J. Biol. Sci."},{"key":"57594_CR20","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.2174\/1871520622666220501162351","volume":"22","author":"T Angre","year":"2022","unstructured":"Angre, T., Kumar, A., Singh, A. K., Thareja, S. & Kumar, P. Role of collagen regulators in cancer treatment: a comprehensive review. Anticancer Agents Med. Chem. 22, 2956\u20132984 (2022).","journal-title":"Anticancer Agents Med. Chem."},{"key":"57594_CR21","doi-asserted-by":"publisher","first-page":"10509","DOI":"10.3390\/ijms231810509","volume":"23","author":"K Song","year":"2022","unstructured":"Song, K. et al. Collagen remodeling along cancer progression providing a novel opportunity for cancer diagnosis and treatment. Int. J. Mol. Sci. 23, 10509 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"57594_CR22","doi-asserted-by":"publisher","first-page":"108311","DOI":"10.1016\/j.intimp.2021.108311","volume":"101","author":"W Li","year":"2021","unstructured":"Li, W., Yin, X., Yan, Y., Liu, C. & Li, G. STEAP4 knockdown inhibits the proliferation of prostate cancer cells by activating the cGMP-PKG pathway under lipopolysaccharide-induced inflammatory microenvironment. Int. Immunopharmacol. 101, 108311 (2021).","journal-title":"Int. Immunopharmacol."},{"key":"57594_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jbt.22749","volume":"35","author":"X Kong","year":"2021","unstructured":"Kong, X., Wang, J. S. & Yang, H. Upregulation of lncRNA DARS-AS1 accelerates tumor malignancy in cervical cancer by activating cGMP-PKG pathway. J. Biochem. Mol. Toxicol. 35, 1\u201311 (2021).","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"57594_CR24","doi-asserted-by":"publisher","first-page":"889656","DOI":"10.3389\/fcell.2022.889656","volume":"10","author":"W Yue","year":"2022","unstructured":"Yue, W. et al. The apoptotic resistance of BRCA1-deficient ovarian cancer cells is mediated by cAMP. Front. Cell Dev. Biol. 10, 889656 (2022).","journal-title":"Front. Cell Dev. Biol."},{"key":"57594_CR25","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s13046-021-02146-8","volume":"40","author":"H Li","year":"2021","unstructured":"Li, H. et al. ZIP10 drives osteosarcoma proliferation and chemoresistance through ITGA10-mediated activation of the PI3K\/AKT pathway. J. Exp. Clin. Cancer Res. 40, 340 (2021).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"57594_CR26","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1074\/mcp.RA118.000596","volume":"17","author":"AG Hawkins","year":"2018","unstructured":"Hawkins, A. G. et al. The Ewing sarcoma secretome and its response to activation of Wnt\/beta-catenin signaling. Mol. Cell Proteomics 17, 901\u2013912 (2018).","journal-title":"Mol. Cell Proteomics"},{"key":"57594_CR27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.bbrc.2021.02.137","volume":"550","author":"M Chen","year":"2021","unstructured":"Chen, M., Jiang, Y. & Sun, Y. KDM4A-mediated histone demethylation of SLC7A11 inhibits cell ferroptosis in osteosarcoma. Biochem. Biophys. Res. Commun. 550, 77\u201383 (2021).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"57594_CR28","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.bbrc.2021.06.036","volume":"567","author":"Y Shi","year":"2021","unstructured":"Shi, Y. et al. Tirapazamine suppress osteosarcoma cells in part through SLC7A11 mediated ferroptosis. Biochem. Biophys. Res. Commun. 567, 118\u2013124 (2021).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"57594_CR29","doi-asserted-by":"publisher","first-page":"722624","DOI":"10.3389\/fonc.2021.722624","volume":"11","author":"J Ding","year":"2021","unstructured":"Ding, J. et al. Knockdown of oligosaccharyltransferase subunit ribophorin 1 induces endoplasmic-reticulum-stress-dependent cell apoptosis in breast cancer. Front. Oncol. 11, 722624 (2021).","journal-title":"Front. Oncol."},{"key":"57594_CR30","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3389\/fncel.2015.00431","volume":"9","author":"JC L\u00f3pez-Ramos","year":"2015","unstructured":"L\u00f3pez-Ramos, J. C., Duran, J., Gruart, A., Guinovart, J. J. & Delgado-Garc\u00eda, J. M. Role of brain glycogen in the response to hypoxia and in susceptibility to epilepsy. Front. Cell Neurosci. 9, 431 (2015).","journal-title":"Front. Cell Neurosci."},{"key":"57594_CR31","doi-asserted-by":"publisher","first-page":"9186","DOI":"10.7150\/thno.46825","volume":"10","author":"SL Chen","year":"2020","unstructured":"Chen, S. L. et al. GYS1 induces glycogen accumulation and promotes tumor progression via the NF-\u03baB pathway in clear cell renal carcinoma. Theranostics. 10, 9186\u20139199 (2020).","journal-title":"Theranostics."},{"key":"57594_CR32","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1093\/bib\/bby073","volume":"20","author":"F Yu","year":"2019","unstructured":"Yu, F. et al. Breast cancer prognosis signature: Linking risk stratification to disease subtypes. Brief. Bioinform. 20, 2130\u20132140 (2019).","journal-title":"Brief. Bioinform."},{"key":"57594_CR33","doi-asserted-by":"publisher","first-page":"17988","DOI":"10.1038\/s41598-023-45295-w","volume":"13","author":"X Wang","year":"2023","unstructured":"Wang, X., Yang, J., Yang, F. & Mu, K. The disulfidptosis-related signature predicts prognosis and immune features in glioma patients. Sci. Rep. 13, 17988 (2023).","journal-title":"Sci. Rep."},{"key":"57594_CR34","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1002\/tox.24051","volume":"39","author":"C Yue","year":"2024","unstructured":"Yue, C. et al. The predictive efficacy of programmed cell death in immunotherapy of melanoma: A comprehensive analysis of gene expression data for programmed cell death biomarker and therapeutic target discovery. Environ. Toxicol. 39, 1858\u20131873 (2024).","journal-title":"Environ. Toxicol."},{"key":"57594_CR35","doi-asserted-by":"publisher","first-page":"e23502","DOI":"10.1016\/j.heliyon.2023.e23502","volume":"10","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. Identification and validation of a disulfidptosis-related genes prognostic signature in lung adenocarcinoma. Heliyon. 10, e23502 (2024).","journal-title":"Heliyon."},{"key":"57594_CR36","doi-asserted-by":"publisher","first-page":"1128390","DOI":"10.3389\/fimmu.2023.1128390","volume":"14","author":"K Hong","year":"2023","unstructured":"Hong, K. et al. Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy. Front. Immunol. 14, 1128390 (2023).","journal-title":"Front. Immunol."},{"key":"57594_CR37","doi-asserted-by":"publisher","first-page":"1094793","DOI":"10.3389\/fgene.2023.1094793","volume":"14","author":"H Qin","year":"2023","unstructured":"Qin, H. et al. Comprehensive analysis of cuproptosis-related prognostic gene signature and tumor immune microenvironment in HCC. Front. Genet. 14, 1094793 (2023).","journal-title":"Front. Genet."},{"key":"57594_CR38","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3390\/genes10060414","volume":"10","author":"F Liu","year":"2019","unstructured":"Liu, F., Xing, L., Zhang, X. & Zhang, X. A four-pseudogene classifier identified by machine learning serves as a novel prognostic marker for survival of osteosarcoma. Genes (Basel) 10, 414 (2019).","journal-title":"Genes (Basel)"},{"key":"57594_CR39","doi-asserted-by":"publisher","first-page":"3486","DOI":"10.18632\/aging.102824","volume":"12","author":"C Zhang","year":"2020","unstructured":"Zhang, C. et al. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma. Aging (Albany NY). 12, 3486\u20133501 (2020).","journal-title":"Aging (Albany NY)."},{"key":"57594_CR40","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1186\/s12885-021-09042-6","volume":"21","author":"R Liu","year":"2021","unstructured":"Liu, R., Hu, Y., Liu, T. & Wang, Y. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma cancer. BMC Cancer 21, 1345 (2021).","journal-title":"BMC Cancer"},{"key":"57594_CR41","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nri3073","volume":"11","author":"PJ Murray","year":"2011","unstructured":"Murray, P. J. & Wynn, T. A. Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 11, 723\u2013737 (2011).","journal-title":"Nat. Rev. Immunol."},{"key":"57594_CR42","doi-asserted-by":"publisher","first-page":"5207","DOI":"10.3390\/ijms21155207","volume":"21","author":"F Cersosimo","year":"2020","unstructured":"Cersosimo, F. et al. Tumor-associated macrophages in osteosarcoma: From mechanisms to therapy. Int. J. Mol. Sci. 21, 5207 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"57594_CR43","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1158\/1078-0432.CCR-20-4226","volume":"27","author":"PJ Galbo","year":"2021","unstructured":"Galbo, P. J., Zang, X. & Zheng, D. Molecular features of cancer-associated fibroblast subtypes and their implication on cancer pathogenesis, prognosis, and immunotherapy resistance. Clin. Cancer Res. 27, 2636\u20132647 (2021).","journal-title":"Clin. Cancer Res."},{"key":"57594_CR44","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","volume":"18","author":"X Chen","year":"2019","unstructured":"Chen, X. & Song, E. Turning foes to friends: Targeting cancer-associated fibroblasts. Nat. Rev. Drug Discov. 18, 99\u2013115 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"57594_CR45","doi-asserted-by":"crossref","unstructured":"Wrenn, E. D. et al. Carcinoma-associated fibroblast-like tumor cells remodel the Ewing sarcoma tumor microenvironment. bioRxiv (2023).","DOI":"10.1101\/2023.04.12.536619"},{"key":"57594_CR46","doi-asserted-by":"publisher","first-page":"5877","DOI":"10.7150\/thno.73714","volume":"12","author":"X Huang","year":"2022","unstructured":"Huang, X., Wang, L., Guo, H., Zhang, W. & Shao, Z. Single-cell transcriptomics reveals the regulative roles of cancer associated fibroblasts in tumor immune microenvironment of recurrent osteosarcoma. Theranostics. 12, 5877\u20135887 (2022).","journal-title":"Theranostics."},{"key":"57594_CR47","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s11912-018-0718-6","volume":"20","author":"DJ Palmieri","year":"2018","unstructured":"Palmieri, D. J. & Carlino, M. S. Immune checkpoint inhibitor toxicity. Curr. Oncol. Rep. 20, 72 (2018).","journal-title":"Curr. Oncol. Rep."},{"key":"57594_CR48","doi-asserted-by":"publisher","first-page":"7016","DOI":"10.3390\/ijms22137016","volume":"22","author":"M Kaiser","year":"2021","unstructured":"Kaiser, M. et al. Immune aging and immunotherapy in cancer. Int. J. Mol. Sci. 22, 7016 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"57594_CR49","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.immuni.2021.12.010","volume":"55","author":"L Sivapalan","year":"2022","unstructured":"Sivapalan, L. & Anagnostou, V. Genetic variation in antigen presentation and cancer immunotherapy. Immunity. 55, 3\u20136 (2022).","journal-title":"Immunity."},{"key":"57594_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/21645515.2021.1891814","volume":"18","author":"Y Yu","year":"2022","unstructured":"Yu, Y. et al. Neoantigen-reactive T cells exhibit effective anti-tumor activity against colorectal cancer. Hum. Vaccin. Immunother. 18, 1\u201311 (2022).","journal-title":"Hum. Vaccin. Immunother."},{"key":"57594_CR51","first-page":"7741","volume":"15","author":"L Ni","year":"2023","unstructured":"Ni, L., Yang, H., Wu, X., Zhou, K. & Wang, S. The expression and prognostic value of disulfidptosis progress in lung adenocarcinoma. Aging (Albany NY). 15, 7741\u20137759 (2023).","journal-title":"Aging (Albany NY)."},{"key":"57594_CR52","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1186\/s40001-023-01535-3","volume":"28","author":"J Zhao","year":"2023","unstructured":"Zhao, J. et al. Disulfidptosis-related signatures for prognostic and immunotherapy reactivity evaluation in hepatocellular carcinoma. Eur. J. Med. Res. 28, 571 (2023).","journal-title":"Eur. J. Med. Res."},{"key":"57594_CR53","doi-asserted-by":"publisher","first-page":"1254119","DOI":"10.3389\/fphar.2023.1254119","volume":"14","author":"HB Zhang","year":"2023","unstructured":"Zhang, H. B., Pan, J. Y. & Zhu, T. A disulfidptosis-related lncRNA prognostic model to predict survival and response to immunotherapy in lung adenocarcinoma. Front. Pharmacol. 14, 1254119 (2023).","journal-title":"Front. Pharmacol."},{"key":"57594_CR54","doi-asserted-by":"publisher","first-page":"558","DOI":"10.3390\/cancers13030558","volume":"13","author":"A Rizzo","year":"2021","unstructured":"Rizzo, A., Ricci, A. D. & Brandi, G. PD-L1, TMB, MSI, and other predictors of response to immune checkpoint inhibitors in biliary tract cancer. Cancers (Basel) 13, 558 (2021).","journal-title":"Cancers (Basel)"},{"key":"57594_CR55","doi-asserted-by":"publisher","first-page":"100336","DOI":"10.1016\/j.esmoop.2021.100336","volume":"7","author":"M Palmeri","year":"2022","unstructured":"Palmeri, M. et al. Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers. ESMO Open. 7, 100336 (2022).","journal-title":"ESMO Open."},{"key":"57594_CR56","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1097\/PAI.0000000000000575","volume":"26","author":"L Chang","year":"2018","unstructured":"Chang, L., Chang, M., Chang, H. M. & Chang, F. Microsatellite instability: A predictive biomarker for cancer immunotherapy. Appl. Immunohistochem. Mol. Morphol. 26, e15\u2013e21 (2018).","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"57594_CR57","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3389\/fimmu.2020.00369","volume":"11","author":"E Picard","year":"2020","unstructured":"Picard, E., Verschoor, C. P., Ma, G. W. & Pawelec, G. Relationships between immune landscapes, genetic subtypes and responses to immunotherapy in colorectal cancer. Front. Immunol. 11, 369 (2020).","journal-title":"Front. Immunol."},{"key":"57594_CR58","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41568-021-00366-w","volume":"21","author":"D Bayik","year":"2021","unstructured":"Bayik, D. & Lathia, J. D. Cancer stem cell-immune cell crosstalk in tumour progression. Nat. Rev. Cancer 21, 526\u2013536 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"57594_CR59","doi-asserted-by":"publisher","first-page":"3634","DOI":"10.1111\/jcmm.16469","volume":"25","author":"X Zhang","year":"2021","unstructured":"Zhang, X. et al. M6A regulator-mediated RNA methylation modification patterns are involved in immune microenvironment regulation of periodontitis. J. Cell Mol. Med. 25, 3634\u20133645 (2021).","journal-title":"J. Cell Mol. Med."},{"key":"57594_CR60","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41571-018-0004-4","volume":"15","author":"A Koch","year":"2018","unstructured":"Koch, A. et al. Analysis of DNA methylation in cancer: Location revisited. Nat. Rev. Clin. Oncol. 15, 459\u2013466 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"57594_CR61","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1186\/s12859-021-04416-w","volume":"22","author":"Y Pu","year":"2021","unstructured":"Pu, Y., Li, C., Yuan, H. & Wang, X. Identification of prostate cancer specific methylation biomarkers from a multi-cancer analysis. BMC Bioinform. 22, 492 (2021).","journal-title":"BMC Bioinform."},{"key":"57594_CR62","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1586\/erm.12.45","volume":"12","author":"T Mikeska","year":"2012","unstructured":"Mikeska, T., Bock, C., Do, H. & Dobrovic, A. DNA methylation biomarkers in cancer: Progress towards clinical implementation. Expert Rev. Mol. Diagn. 12, 473\u2013487 (2012).","journal-title":"Expert Rev. Mol. Diagn."},{"key":"57594_CR63","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ejca.2022.10.015","volume":"178","author":"J Ibrahim","year":"2023","unstructured":"Ibrahim, J., Peeters, M., Van Camp, G. & Op, D. B. K. Methylation biomarkers for early cancer detection and diagnosis: Current and future perspectives. Eur. J. Cancer 178, 91\u2013113 (2023).","journal-title":"Eur. J. Cancer"},{"key":"57594_CR64","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/ijc.29684","volume":"138","author":"B Gy\u0151rffy","year":"2016","unstructured":"Gy\u0151rffy, B. et al. Aberrant DNA methylation impacts gene expression and prognosis in breast cancer subtypes. Int. J. Cancer 138, 87\u201397 (2016).","journal-title":"Int. J. Cancer"},{"key":"57594_CR65","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13148-022-01337-0","volume":"14","author":"P Li","year":"2022","unstructured":"Li, P. et al. Liquid biopsies based on DNA methylation as biomarkers for the detection and prognosis of lung cancer. Clin. Epigenet. 14, 118 (2022).","journal-title":"Clin. Epigenet."},{"key":"57594_CR66","doi-asserted-by":"publisher","first-page":"1101683","DOI":"10.3389\/fgene.2023.1101683","volume":"14","author":"H Qin","year":"2023","unstructured":"Qin, H. et al. Identification and verification of m7G-related genes as biomarkers for prognosis of sarcoma. Front. Genet. 14, 1101683 (2023).","journal-title":"Front. Genet."},{"key":"57594_CR67","doi-asserted-by":"publisher","first-page":"624","DOI":"10.3390\/cells9030624","volume":"9","author":"V Const\u00e2ncio","year":"2020","unstructured":"Const\u00e2ncio, V., Nunes, S. P., Henrique, R. & Jer\u00f3nimo, C. DNA methylation-based testing in liquid biopsies as detection and prognostic biomarkers for the four major cancer types. Cells-Basel 9, 624 (2020).","journal-title":"Cells-Basel"},{"key":"57594_CR68","doi-asserted-by":"publisher","first-page":"12627","DOI":"10.1007\/s13277-016-5147-2","volume":"37","author":"K Hudcova","year":"2016","unstructured":"Hudcova, K. et al. Expression profiles of miR-29c, miR-200b and miR-375 in tumour and tumour-adjacent tissues of head and neck cancers. Tumour Biol. 37, 12627\u201312633 (2016).","journal-title":"Tumour Biol."},{"key":"57594_CR69","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13000-019-0893-2","volume":"14","author":"R Fang","year":"2019","unstructured":"Fang, R., Huang, Y., Xie, J., Zhang, J. & Ji, X. Downregulation of miR-29c-3p is associated with a poor prognosis in patients with laryngeal squamous cell carcinoma. Diagn. Pathol. 14, 109 (2019).","journal-title":"Diagn. Pathol."},{"key":"57594_CR70","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12920-023-01554-3","volume":"16","author":"Y Ju","year":"2023","unstructured":"Ju, Y. et al. Identification of miR-143-3p as a diagnostic biomarker in gastric cancer. BMC Med. Genomics 16, 135 (2023).","journal-title":"BMC Med. Genomics"},{"key":"57594_CR71","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s13402-020-00565-x","volume":"44","author":"T Lu","year":"2021","unstructured":"Lu, T. et al. Circular RNA circCSNK1G3 induces HOXA10 signaling and promotes the growth and metastasis of lung adenocarcinoma cells through hsa-miR-143-3p sponging. Cell Oncol. (Dordr). 44, 297\u2013310 (2021).","journal-title":"Cell Oncol. (Dordr)."},{"key":"57594_CR72","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.3390\/cancers7040884","volume":"7","author":"A Silva","year":"2015","unstructured":"Silva, A., Bullock, M. & Calin, G. The clinical relevance of long non-coding RNAs in cancer. Cancers (Basel). 7, 2169\u20132182 (2015).","journal-title":"Cancers (Basel)."},{"key":"57594_CR73","doi-asserted-by":"publisher","first-page":"106600","DOI":"10.1016\/j.intimp.2020.106600","volume":"84","author":"X Zhang","year":"2020","unstructured":"Zhang, X. et al. Identification of immune-related lncRNAs in periodontitis reveals regulation network of gene-lncRNA-pathway-immunocyte. Int. Immunopharmacol. 84, 106600 (2020).","journal-title":"Int. Immunopharmacol."},{"key":"57594_CR74","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.21037\/gs-21-84","volume":"10","author":"C Liu","year":"2021","unstructured":"Liu, C. et al. Upregulation of LINC00511 expression by DNA hypomethylation promotes the progression of breast cancer. Gland Surg. 10, 1418\u20131430 (2021).","journal-title":"Gland Surg."},{"key":"57594_CR75","doi-asserted-by":"publisher","first-page":"394","DOI":"10.4251\/wjgo.v12.i4.394","volume":"12","author":"CB Sun","year":"2020","unstructured":"Sun, C. B. et al. LINC00511 promotes gastric cancer cell growth by acting as a ceRNA. World J. Gastrointest. Oncol. 12, 394\u2013404 (2020).","journal-title":"World J. Gastrointest. Oncol."},{"key":"57594_CR76","first-page":"A68","volume":"19","author":"K Tomczak","year":"2015","unstructured":"Tomczak, K., Czerwi\u0144ska, P. & Wiznerowicz, M. The Cancer Genome Atlas (TCGA): An immeasurable source of knowledge. Contemp. Oncol. (Pozn). 19, A68\u2013A77 (2015).","journal-title":"Contemp. Oncol. (Pozn)."},{"key":"57594_CR77","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson, M. D. & Hayes, D. N. ConsensusClusterPlus: A class discovery tool with confidence assessments and item tracking. Bioinformatics 26, 1572\u20131573 (2010).","journal-title":"Bioinformatics"},{"key":"57594_CR78","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"57594_CR79","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L. G., Han, Y. & He, Q. Y. ClusterProfiler: An R package for comparing biological themes among gene clusters. Omics 16, 284\u2013287 (2012).","journal-title":"Omics"},{"key":"57594_CR80","doi-asserted-by":"publisher","first-page":"i555","DOI":"10.1093\/bioinformatics\/bty271","volume":"34","author":"RK Powers","year":"2018","unstructured":"Powers, R. K., Goodspeed, A., Pielke-Lombardo, H., Tan, A. C. & Costello, J. C. GSEA-InContext: Identifying novel and common patterns in expression experiments. Bioinformatics. 34, i555\u2013i564 (2018).","journal-title":"Bioinformatics."},{"key":"57594_CR81","doi-asserted-by":"publisher","first-page":"W60","DOI":"10.1093\/nar\/gky311","volume":"46","author":"M Franz","year":"2018","unstructured":"Franz, M. et al. GeneMANIA update 2018. Nucleic Acids Res. 46, W60\u2013W64 (2018).","journal-title":"Nucleic Acids Res."},{"key":"57594_CR82","doi-asserted-by":"publisher","first-page":"bbac558","DOI":"10.1093\/bib\/bbac558","volume":"24","author":"CJ Liu","year":"2023","unstructured":"Liu, C. J. et al. GSCA: An integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels. Brief. Bioinform. 24, bbac558 (2023).","journal-title":"Brief. Bioinform."},{"key":"57594_CR83","first-page":"D1031","volume":"48","author":"Y Wang","year":"2020","unstructured":"Wang, Y. et al. Therapeutic target database 2020: Enriched resource for facilitating research and early development of targeted therapeutics. Nucleic Acids Res. 48, D1031\u2013D1041 (2020).","journal-title":"Nucleic Acids Res."},{"key":"57594_CR84","doi-asserted-by":"publisher","first-page":"D991","DOI":"10.1093\/nar\/gks1193","volume":"41","author":"T Barrett","year":"2013","unstructured":"Barrett, T. et al. NCBI GEO: Archive for functional genomics data sets-update. Nucleic Acids Res. 41, D991\u2013D995 (2013).","journal-title":"Nucleic Acids Res."},{"key":"57594_CR85","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/978-1-0716-0327-7_16","volume":"2120","author":"G Sturm","year":"2020","unstructured":"Sturm, G., Finotello, F. & List, M. Immunedeconv: An R package for unified access to computational methods for estimating immune cell fractions from bulk RNA-sequencing data. Methods Mol. Biol. 2120, 223\u2013232 (2020).","journal-title":"Methods Mol. Biol."},{"key":"57594_CR86","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13059-016-1028-7","volume":"17","author":"B Li","year":"2016","unstructured":"Li, B. et al. Comprehensive analyses of tumor immunity: Implications for cancer immunotherapy. Genome Biol. 17, 174 (2016).","journal-title":"Genome Biol."},{"key":"57594_CR87","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran, D., Hu, Z. & Butte, A. J. XCell: Digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 18, 220 (2017).","journal-title":"Genome Biol."},{"key":"57594_CR88","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","volume":"17","author":"E Becht","year":"2016","unstructured":"Becht, E. et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 17, 218 (2016).","journal-title":"Genome Biol."},{"key":"57594_CR89","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman, A. M. et al. Robust enumeration of cell subsets from tissue expression profiles. Nat. Methods 12, 453\u2013457 (2015).","journal-title":"Nat. Methods"},{"key":"57594_CR90","doi-asserted-by":"publisher","first-page":"e26476","DOI":"10.7554\/eLife.26476","volume":"6","author":"J Racle","year":"2017","unstructured":"Racle, J., de Jonge, K., Baumgaertner, P., Speiser, D. E. & Gfeller, D. Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data. ELIFE 6, e26476 (2017).","journal-title":"ELIFE"},{"key":"57594_CR91","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13073-019-0638-6","volume":"11","author":"F Finotello","year":"2019","unstructured":"Finotello, F. et al. Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data. Genome Med. 11, 34 (2019).","journal-title":"Genome Med."},{"key":"57594_CR92","doi-asserted-by":"publisher","first-page":"W242","DOI":"10.1093\/nar\/gkab418","volume":"49","author":"C Li","year":"2021","unstructured":"Li, C., Tang, Z., Zhang, W., Ye, Z. & Liu, F. GEPIA2021: Integrating multiple deconvolution-based analysis into GEPIA. Nucleic Acids Res. 49, W242\u2013W246 (2021).","journal-title":"Nucleic Acids Res."},{"key":"57594_CR93","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann, S., Castelo, R. & Guinney, J. GSVA: Gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics 14, 7 (2013).","journal-title":"BMC Bioinformatics"},{"key":"57594_CR94","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang, P. et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat. Med. 24, 1550\u20131558 (2018).","journal-title":"Nat. Med."},{"key":"57594_CR95","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.cell.2018.03.034","volume":"173","author":"TM Malta","year":"2018","unstructured":"Malta, T. M. et al. Machine learning identifies stemness features associated with oncogenic dedifferentiation. Cell 173, 338\u2013354 (2018).","journal-title":"Cell"},{"key":"57594_CR96","doi-asserted-by":"publisher","first-page":"D955","DOI":"10.1093\/nar\/gks1111","volume":"41","author":"W Yang","year":"2013","unstructured":"Yang, W. et al. Genomics of drug sensitivity in cancer (GDSC): A resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 41, D955\u2013D961 (2013).","journal-title":"Nucleic Acids Res."},{"key":"57594_CR97","doi-asserted-by":"publisher","first-page":"e107468","DOI":"10.1371\/journal.pone.0107468","volume":"9","author":"P Geeleher","year":"2014","unstructured":"Geeleher, P., Cox, N. & Huang, R. S. PRRophetic: An R package for prediction of clinical chemotherapeutic response from tumor gene expression levels. PLoS One. 9, e107468 (2014).","journal-title":"PLoS One."},{"key":"57594_CR98","doi-asserted-by":"publisher","first-page":"D1420","DOI":"10.1093\/nar\/gkaa1020","volume":"49","author":"D Sun","year":"2021","unstructured":"Sun, D. et al. TISCH: A comprehensive web resource enabling interactive single-cell transcriptome visualization of tumor microenvironment. Nucleic Acids Res. 49, D1420\u2013D1430 (2021).","journal-title":"Nucleic Acids Res."},{"key":"57594_CR99","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li, T. et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 48, W509\u2013W514 (2020).","journal-title":"Nucleic Acids Res."},{"key":"57594_CR100","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1093\/bioinformatics\/bts615","volume":"28","author":"P Loher","year":"2012","unstructured":"Loher, P. & Rigoutsos, I. Interactive exploration of RNA22 microRNA target predictions. Bioinformatics. 28, 3322\u20133323 (2012).","journal-title":"Bioinformatics."},{"key":"57594_CR101","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1093\/bioinformatics\/btp503","volume":"25","author":"S Bandyopadhyay","year":"2009","unstructured":"Bandyopadhyay, S. & Mitra, R. TargetMiner: MicroRNA target prediction with systematic identification of tissue-specific negative examples. Bioinformatics 25, 2625\u20132631 (2009).","journal-title":"Bioinformatics"},{"key":"57594_CR102","doi-asserted-by":"publisher","first-page":"e206239","DOI":"10.1371\/journal.pone.0206239","volume":"13","author":"C Sticht","year":"2018","unstructured":"Sticht, C., De La Torre, C., Parveen, A. & Gretz, N. MiRWalk: An online resource for prediction of microRNA binding sites. PLoS One. 13, e206239 (2018).","journal-title":"PLoS One."},{"key":"57594_CR103","doi-asserted-by":"publisher","first-page":"W244","DOI":"10.1093\/nar\/gkaa467","volume":"48","author":"L Chang","year":"2020","unstructured":"Chang, L., Zhou, G., Soufan, O. & Xia, J. MiRNet 2.0: Network-based visual analytics for miRNA functional analysis and systems biology. Nucleic Acids Res. 48, W244\u2013W251 (2020).","journal-title":"Nucleic Acids Res."},{"key":"57594_CR104","doi-asserted-by":"publisher","first-page":"D92","DOI":"10.1093\/nar\/gkt1248","volume":"42","author":"JH Li","year":"2014","unstructured":"Li, J. H., Liu, S., Zhou, H., Qu, L. H. & Yang, J. H. StarBase V2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 42, D92\u2013D97 (2014).","journal-title":"Nucleic Acids Res."},{"key":"57594_CR105","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon, P. et al. Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498\u20132504 (2003).","journal-title":"Genome Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-57594-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-57594-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-57594-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T10:02:24Z","timestamp":1711447344000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-57594-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,26]]},"references-count":105,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["57594"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-57594-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,26]]},"assertion":[{"value":"19 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7158"}}